SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - FORMA THERAPEUTICS HLDGS INC ownership

FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 99 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q1 2022. The put-call ratio across all filers is 6.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of FORMA THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2022$324,000
-39.2%
16,218
-71.7%
0.01%
-40.0%
Q1 2022$533,000
-34.5%
57,2750.0%0.01%
-52.4%
Q4 2021$814,000
-6.8%
57,275
+52.1%
0.02%
+31.2%
Q3 2021$873,000
+167.0%
37,647
+186.2%
0.02%
+166.7%
Q2 2021$327,000
+39.7%
13,155
+96.5%
0.01%
+50.0%
Q4 2020$234,000
-79.9%
6,695
-71.3%
0.00%
-88.6%
Q3 2020$1,164,00023,3570.04%
Other shareholders
FORMA THERAPEUTICS HLDGS INC shareholders Q1 2022
NameSharesValueWeighting ↓
EDBI Pte Ltd 1,268,805$18,042,0009.80%
Samsara BioCapital, LLC 1,565,526$22,262,0004.32%
Cormorant Asset Management, LP 4,639,995$65,981,0003.92%
Logos Global Management LP 1,600,000$22,752,0002.35%
RA Capital Management 9,011,651$128,146,0002.26%
HighVista Strategies LLC 40,612$578,0000.46%
ARMISTICE CAPITAL, LLC 1,856,000$26,392,0000.43%
Artal Group S.A. 1,000,000$14,220,0000.39%
Parkman Healthcare Partners LLC 100,000$1,422,0000.31%
Integral Health Asset Management, LLC 75,000$1,067,0000.30%
View complete list of FORMA THERAPEUTICS HLDGS INC shareholders